John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 15,000 shares at $31.98 ($475K) on 2014-06-09, disclosed to the SEC on 2014-06-11.
Scheduled sale ($475k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.14 | 3,891 | $121K | 25.5% |
| 2 | $31.19 | 2,200 | $69K | 14.5% |
| 3 | $31.98 | 6,109 | $195K | 41.2% |
| 4 | $31.99 | 2,800 | $90K | 18.9% |
| Total | $31.65 avg | 15,000 | $475K | 100% |
| Filing → |
| XLRN | SELL | 2016-05-20 | $3.3M | — | Filing → |
| XLRN | SELL | 2015-10-09 | $463K | — | Filing → |
| XLRN | SELL | 2015-09-10 | $574K | — | Filing → |